State Street Corp I Teos Therapeutics, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 1,175,353 shares of ITOS stock, worth $8.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,175,353

Previous 963,901 21.94%

Holding current value

$8.53 Million

Previous $14.3 Million 16.11%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.09 - $17.97 $2.13 Million - $3.8 Million	211,452 Added 21.94%	1,175,353 $12 Million
Q2 2024 Aug 14, 2024	BUY	$10.33 - $18.09 $3.99 Million - $6.99 Million	386,356 Added 66.9%	963,901 $14.3 Million
Q1 2024 May 15, 2024	BUY	$9.89 - $13.64 $257,041 - $354,503	25,990 Added 4.71%	577,545 $7.88 Million
Q4 2023 Feb 14, 2024	SELL	$8.57 - $11.06 $8.83 Million - $11.4 Million	-1,029,938 Reduced 65.12%	551,555 $6.04 Million
Q3 2023 Nov 14, 2023	BUY	$10.95 - $14.6 $178,386 - $237,848	16,291 Added 1.04%	1,581,493 $17.3 Million
Q2 2023 Aug 14, 2023	SELL	$12.93 - $18.05 $3.39 Million - $4.73 Million	-262,189 Reduced 14.35%	1,565,202 $20.7 Million
Q1 2023 May 15, 2023	BUY	$13.02 - $22.62 $1.17 Million - $2.04 Million	90,101 Added 5.19%	1,827,391 $24.9 Million
Q4 2022 Feb 14, 2023	SELL	$17.77 - $21.6 $6.59 Million - $8 Million	-370,578 Reduced 17.58%	1,737,290 $33.9 Million
Q3 2022 Nov 15, 2022	SELL	$18.6 - $27.25 $6.89 Million - $10.1 Million	-370,464 Reduced 14.95%	2,107,868 $40.2 Million
Q2 2022 Aug 15, 2022	BUY	$16.57 - $35.1 $12.7 Million - $26.9 Million	766,441 Added 44.77%	2,478,332 $51.1 Million
Q1 2022 May 16, 2022	BUY	$31.92 - $47.45 $30.3 Million - $45 Million	948,540 Added 124.26%	1,711,891 $55.1 Million
Q4 2021 Feb 14, 2022	BUY	$26.23 - $47.86 $11.6 Million - $21.1 Million	441,244 Added 136.99%	763,351 $35.5 Million
Q3 2021 Nov 15, 2021	BUY	$23.91 - $29.58 $94,157 - $116,486	3,938 Added 1.24%	322,107 $8.7 Million
Q2 2021 Aug 16, 2021	SELL	$17.9 - $36.1 $6.89 Million - $13.9 Million	-384,841 Reduced 54.74%	318,169 $8.16 Million
Q1 2021 May 17, 2021	BUY	$30.86 - $44.2 $15.9 Million - $22.7 Million	514,008 Added 271.96%	703,010 $24 Million
Q4 2020 Feb 16, 2021	BUY	$21.59 - $33.95 $1.25 Million - $1.96 Million	57,773 Added 44.02%	189,002 $6.39 Million
Q3 2020 Nov 10, 2020	BUY	$17.57 - $32.92 $2.31 Million - $4.32 Million	131,229 New	131,229 $3.24 Million

Others Institutions Holding ITOS

# of Institutions

166

Shares Held

36.6M

Call Options Held

1.95M

Put Options Held

374K

View Full List

About iTeos Therapeutics, Inc.

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $258M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

More about ITOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp I Teos Therapeutics, Inc. Transaction History